| Trial Name | Denosumab in Giant Cell Tumour |
| Description | Safety study of denosumab in patients with recurrent or unresectable giant cell tumor of bone |
| Reference | Sponsor: Amgen |
| Status / Sites | Open Royal Orthopaedic Hospital, Birmingham |
| UK Chief Investigator Contact | Mr Rob Grimer |
You are viewing the text version of this site.
To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.
Need help? check the requirements page.